News

Volpi Rosse Menarini Team Prepares for Upcoming Basketball Season

Volpi Rosse Menarini Team Prepares for Upcoming Basketball Season

Volpi Rosse Menarini Team Ready for Competitive Season

Italian wheelchair basketball team Volpi Rosse Menarini, proudly sponsored by Menarini, recently revealed their new roster to the enthusiastic press and public in Italy. As they gear up to face challenges in the Italian Serie A and Eurocup 3, anticipation is mounting for an exciting season ahead.

A Diverse Team United by a Common Goal

This season will showcase ten international talents, each bringing unique skills and experiences to the court. Representing various countries including Spain, Finland, Sweden, France, Italy, and Brazil, the Volpi Rosse Menarini aims to highlight the power of teamwork and passion in achieving success. The FIPIC Serie A championship and the esteemed Eurocup 3 await this talented lineup, prepared to compete fiercely starting with their opening match.

From Local to International Arena

The Volpi Rosse Menarini not only works hard to excel in competitions but also places significant emphasis on personal growth through sports. Founded in 2005, this team stands as an example of how sports can foster inclusion and boost collective morale. Affected by the spirit of determination and ethical values, every game becomes an opportunity to inspire and unify.

Lucia and Alberto Giovanni Aleotti, key members of the Menarini Board, expressed deep connection with the team's journey, stating, "It is as if we are two communicating vessels. The Volpi Rosse Menarini shares our commitment to growth and improvement every day." Their support underscores the commitment to advancing both sport and solidarity.

Promoting Inclusion Beyond the Court

In addition to their on-court initiatives, the Volpi Rosse Menarini team is deeply devoted to promoting awareness and inclusion through various projects in local schools. These efforts help create a more inclusive community and inspire future generations about the significance of inclusivity in sports and beyond.

Expanding the Reach of Menarini

The Menarini Group extends its support internationally. The team’s efforts resonate beyond Italy, as they proudly sponsor the Menarini Joventut wheelchair basketball team in Spain. This commitment showcases Menarini's dedication to nurturing a more aware and engaged community, emphasizing unity in diversity.

Achievements and Commitment to Excellence

The journey of Volpi Rosse Menarini began with a vision for promoting social initiatives. Over the years, they have accomplished remarkable feats in wheelchair basketball, including significant placements such as winning the UISP Italian Championship in the 2017/18 season. After a challenging period due to the pandemic, they made a remarkable comeback, securing top positions in Serie B and Serie A in subsequent seasons.

Notably, the 2022/23 season saw the team finish sixth in the league and win the Eurocup 3 Tournament held in France. Their passion and competitive spirit clearly illustrate their ability to rise above challenges and strive for greatness.

The Menarini Group’s Commitment to Health

The Menarini Pharmaceutical Group, headquartered in Florence, continues to make strides globally, operating in 140 countries. With a consolidated turnover of €4,603 million and over 17,000 dedicated employees, Menarini maintains high standards in the pharma sector, producing over 609 million packets annually across crucial areas of healthcare such as cardiology, oncology, and more.

Looking Ahead

The upcoming games will truly be a testament to the hard work and dedication of both the athletes and coaches of the Volpi Rosse Menarini. With the backing of Menarini, the team is set to make significant strides in the upcoming season. As they prepare to take on rivals both locally and in the Eurocup 3, their focus remains unwavering, showcasing their skill, determination, and the spirit of inclusion that defines them.

Frequently Asked Questions

1. What is the Volpi Rosse Menarini team?

The Volpi Rosse Menarini is an Italian wheelchair basketball team supported by the Menarini Pharmaceutical Group, focusing on competition and inclusion.

2. When does the season start?

The season kicks off with matches in both the FIPIC Serie A championship and Eurocup 3, beginning soon.

3. What makes this team special?

The team is unique due to its diverse international roster and commitment to fostering inclusion through sports.

4. How has Menarini supported the team?

The Menarini Group has sponsored the Volpi Rosse Menarini since 2011, emphasizing shared values of solidarity and sportsmanship.

5. What achievements has the team accomplished?

The team has seen significant success, including finishing sixth in Serie A and winning the Eurocup 3 in recent years.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

New Insights from Dupixent® and Itepekimab at ERS 2024

Updated Category News Views 281

Scientific Innovation in Respiratory Diseases Recent findings presented at the European Respiratory Society (ERS) Congress highlight remarkable progress in treating chronic obstructive pulmonary disease (COPD), asthma, and chronic rhinosinusitis with nasal polyps (CRSwNP). With a total of 20 abstracts, including four oral presentations, researchers have unveiled new...

Continue Reading
Marketeam.ai Secures Top Honors for AI Marketing Innovation

Updated Category News Views 154

Marketeam.ai Shines at the AI Breakthrough Awards Marketeam.ai has recently received the prestigious 'Proactive AI Assistance Solution of the Year' award at the annual AI Breakthrough Awards, a celebration of innovation in artificial intelligence. This recognition highlights the pioneering role Marketeam.ai plays in the field of automated marketing solutions. Innovative...

Continue Reading
LightPath Technologies Secures Major Order for Infrared Cameras

Updated Category News Views 90

Significant Purchase Order Announcement LightPath Technologies, Inc. (NASDAQ: LPTH) has recently announced a substantial $9.6 million purchase order for cooled infrared cameras from a valued defense customer. This order emphasizes the company’s strong partnership with its client and highlights the increasing demand for advanced imaging systems in defense and security...

Continue Reading
Earnings Season Insights: Major Bank Reports Highlight Trends

Updated Category News Views 249

Earnings Season Insights: What the Reports Reveal The recent earnings reports from major banks have painted a mixed yet insightful picture of the current economic landscape. These reports indicate a strong start to the Q2 earnings season, driven primarily by trading and investment banking activities. Despite the impressive results, CEOs have expressed a cautious stance...

Continue Reading
Alumis and ACELYRIN Merger: A Transformative Step Forward

Updated Category News Views 197

Alumis Finalizes Strategic Merger with ACELYRIN In a significant development, Alumis Inc. (Nasdaq: ALMS), a biopharma company specializing in innovative therapies for immune-mediated diseases, has officially completed its merger with ACELYRIN, Inc. This merger marks a pivotal moment for Alumis as it strengthens its position in the biopharmaceutical industry. Details of...

Continue Reading